Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors

Clinical trial NCT01831089 · COMPLETED

Trial details

NCT number: NCT01831089
Sponsor: PharmaMar
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Ovarian Cancer Gynecological Cancer Head and Neck Carcinoma Non-small Cell Lung Cancer Small Cell Lung Cancer Non-squamous Cell Lung Cancer

Start date: 2013-09-01
Primary completion: 2016-07-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.